Możliwości wykorzystywania probiotyków i witamin w zarządzaniu procesem terapeutycznym w cukrzycy

• Autorzy: Katarzyna Sygit , Marian Sygit , Jan Krakowiak , Izabela Gąska

Warianty tytułu

Possibilities of Using Probiotics and Vitamins in Managing the Therapeutic Process of Diabetes

• Języki publikacji: PL

Abstrakty

EN

Introduction. The commonly used therapeutic methods do not fully meet the expectations of patients with diabetes. Numerous patients who have type 2 diabetes use or try to use 'various own' methods of treatment. Objective. The purpose of this paper is to present the first results of research on 'bacterial character of diabetes', based on the fact that probiotic bacterial strains have been created, which - in appropriate doses - have a pro-health effect according to WHO, and based on reports on beneficial vitamin therapy in the treatment of many diseases - as an op- portunity to use probiotics and vitamins in managing the therapeutic process in diabetes. Results. The analysis included sugar levels in 1008 tests, depending on the various treatments for non-insulin dependent diabetes, namely: 1. Probiotics, vitamins (B and C), anti-diabetic diet, anti-diabetic drugs; 2. Anti-diabetic diet, anti-diabetic drugs; 3. Probio- tics, anti-diabetic diet, anti-diabetic drugs; Additionally: probiotics and anti-diabetic diet; probiotics and anti-diabetic drugs; probiotics and physical activity; probiotics and vitamins. Conclusions. It was shown that the use of probiotics contributed to the reduction of blood sugar levels, in particular in combination with physical activity and the use of vitamins (B and C), using the possibility of introducing changes in the management of the therapeutic process in diabetes. (original abstract)

Słowa kluczowe

PL

Zdrowie; Witaminy

EN

Health; Vitamins

• Czasopismo: Przedsiębiorczość i Zarządzanie
• Rocznik: 2018
• Numer: t. 19, z. 12, cz. 2 Współczesne problemy zarządzania publicznego
• Strony: 367--379

Twórcy

autor

Katarzyna Sygit

• Uniwersytet Szczeciński

autor

Marian Sygit

• Uniwersytet Szczeciński

autor

Jan Krakowiak

• Uniwersytet Medyczny w Łodzi

autor

Izabela Gąska

• Państwowa Wyższa Szkoła Zawodowa im. Jana Grodka w Sanoku

Bibliografia

• Allen S.J., Okoko B., Martinez E. (2003), Probiotics for treating infectious diarrhoea, "The Cochra- ne Database of Systematic Reviews", z. 4, nr 2, ss. 93-101.
• Bartlett J.G. (2002), Antibiotic-associated diarrhoea, "The New England Journal of Medicine", z. 346, nr 14, ss. 334-339.
• Bassuk S.S., Manson J.E. (2005), Epidemiological evidence for the role of physical activity in redu- cing risk of type 2 diabetes and cardiovascular disease, "Journal of Applied Physiology", z. 99, nr 3, ss. 1193-1204.
• Berger M., Kemmer F.W., Becker K., Herberg L., Schwenen M., Gjinavci A., Berchtold P. (1979), Effect of physical training on glucose tolerance and on glucose metabolism of skeletal muscle in ana- esthetized normal rats, "Diabetologia", z. 16, nr 3, ss. 179-184.
• Corpeleijn E., Feskens E.J., Jansen E.H., Mensink M., Saris W.H., Blaak E.E. (2007), Lifesty- le intervention and adipokine levels in subjects at high risk for type 2 diabetes: the Study on Life- style intervention and Impaired glucose tolerance Maastricht (SLIM), "Diabetes Care", z. 30, nr 12, ss. 3125-3127.
• Derentowicz P. (2018), Probiotyki a zdrowie człowieka, "Moda na zdrowie", z. 2, nr 40, ss. 35-42.
• Drzycimska-Tatka B., Drab-Rybczyńska A., Kasprzak J. (2011), Zespół metaboliczny - epidemia XXI wieku, "Hygeia Public Health" z. 46, nr 4, ss. 423-430.
• Ewaschuck J.B., Madsen K.L. (2009), Mechanisms of probiotic effects: a review, "Functional Food Rev."z. 1, nr 6, ss. 29-41.
• Floch M.H., Walker W.A., Guandalini S. (2008), Recommendations for probiotic use - 2008, "J. Clin. Gastroenterol." z. 42, nr 2, ss.104-108.
• Gilliland S.E., Speck M.L. (1977), Enumeration and identity of lactobacilli in dietary products, "Journal of Food Protection", z. 40, nr 6, ss. 760-762.
• Goldin B.R., Salminen S. (1998), Lacticacid bacteria and gut mucosal barrier function, "Gastroen- terology Inter.", z. 11, nr 14, ss. 69-73.
• Guyatt G., Rennie D. (red.) (2002), Users' guides to the medical literature, American Medical As- sociation.
• Hamilton-Miller J.M., Shah S., Smith C.T. (1996), "Probiotic" remedies are no what they seem, "Br. Med. J.", z.312, nr 23, ss. 55-56.
• Huang J.S., Bousvaros A., Lee J.W. (2002), Efficacy of probiotic use in acute diarrhea in children: a meta-analysis, "Dig. Dis. Sci." z. 47, nr 8, ss. 625-634.
• Kurpas D., Czech T., Mroczek B. (2012), The quality of life of patients with diabetes - importance of complications, "Family Medicine & Primary Care Review", z. 14, nr 2, ss. 177-181.
• Nowak A., Śliżewska K. (2010), Probiotyki - efekty zdrowotne, "Żywność. Nauka. Technologia. Jakość", z. 4, nr 71, ss. 20-39.
• Nowak A., Śliżewska K., Libudzisz Z. (2010), Probiotyki - historia i mechanizmy działania, "Żywność. Nauka. Technologia. Jakość", z. 4, nr 71, ss. 5-19.
• Kligler B., Hanaway P., Cohrssen A. (2007), Probiotics in children, "Pediatr. Clin. North Am." z. 54, nr 4, ss. 949-967.
• Marteau P.R., de Vrese M., Cellier C.J. (2001), Protection from gastrointestinal diseases with the use of probiotics, "Am. J. Clin. Nutr." z. 73, nr 16, ss. 430-340.
• Rolfe R.D. (2000), The role of probiotic cultures in the control of gastrointestinal health, "J. Nutr." , z. 130, nr 19, ss.396-402.
• Segel S.A., Paramore D.S., Cryer P.E. (2002), Hypoglycemia-associated autonomic failure in ad- vanced type 2 diabetes, "Diabetes", z. 51, nr 3, ss. 724-733.
• Steinka I. (2011), Wybrane aspekty stosowania probiotyków, "Am. Acad. Med. Geclan.", z. 41, nr 4, ss. 97-108.
• Sygit M. (2017), Zdrowie Publiczne, "Wolters Kluwer", Warszawa.
• Sygit K., Sygit M., Eider J. (2017), The change of HbA1c parameters and the Body Mass Index In diabetes treatment cycle depending on the frequency of the undertaken physical activity program, "Handel Wewnętrzny", z. 4, nr 369, ss. 412-424.
• Sygit M., Sygit K., Karkowski T., Krakowiak J. (2018), Lifestyle versus a persons's life span, "Central European Journal of Sport Sciences and Medicine", z. 22, nr 2, ss. 51-60.
• Szajewska H. (2010), Probiotyki w Polsce - kiedy jakie i dlaczego?, "Gastroenterologia Kliniczna", z. 2, nr 1, ss. 1-9.
• Szajewska H., Fordymacka A., Badrowski J. (2004), Microbiological and genetic analysis of probiotic products licensed for medicinal purposes, "Med. Sci. Monit.", z. 10, nr 6, ss. 346-350.
• Szajewska H., Mrukowicz J. (2001), Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, doubleblind, placebo controlled trias,"J. Pediatr. Gastroenterol. Nutr", z. 33, nr 15, ss. 17-25.
• Szybiński Z. (2001), Polish Multicenter Research on Epidemiology of Diabetes (PWBEC) 1998-2000, "Polskie Archiwum Medycyny Wewnętrznej", z. 106, nr 3, ss. 751-758.
• Tokarz-Deptuła B., Śliwa-Dominiak J. (2015), Probiotyki a wybrane schorzenia u ludzi, "Post. Mi- krobiol." , z. 54, nr 2, ss. 133-140.
• Van Niel C., Feudtner C., Garrison M.M. (2002), Lactobacillus therapy for acute infectious diar- rhea in children: a metaanalysis, "Pediatrics", z. 109, nr 34, ss. 678-684.